The Endocrine Journey: Long-Term Monitoring and Care
At a Glance
Children with PCSK1 deficiency may develop hormone problems at different stages, even after earlier tests were normal. Regular, individualized monitoring of growth, thyroid, adrenal function, water balance, blood sugar, and puberty helps clinicians treat changes early.
Because the PC1/3 enzyme is a master regulator for so many different hormones, living with PCSK1 deficiency is a long-term journey of discovery. One of the most challenging aspects for parents is that hormone deficiencies do not always appear all at once. Instead, they often emerge sequentially as a child grows, meaning a “normal” test result today does not guarantee a system will work perfectly next year [1][2].
The Evolving Endocrine Picture
Your medical team will monitor several “axes”—the pathways the brain uses to control different organs. In a review of 26 reported cases, many children developed one or more of the following over time (Note: these percentages come from a very small historical cohort and do not predict an individual child’s course):
- Growth Hormone (GH) Deficiency (44%): This can lead to slowed growth or “failure to thrive” in infancy, and it often requires replacement therapy to help a child reach their growth potential [1][3].
- Central Hypothyroidism (56%): Unlike typical thyroid issues, this starts in the brain’s signaling center. It can cause fatigue, constipation, and slow growth if not treated with daily thyroid hormone [1][4]. Safety Note: The standard TSH blood test can be misleading in central hypothyroidism, so doctors must monitor the “Free T4” level instead. Importantly, adrenal function must be evaluated before starting thyroid replacement to prevent a life-threatening adrenal crisis.
- Central Hypocortisolism (57%): The body may not make enough cortisol, the hormone that helps us handle stress and illness. While we cover the emergency signs elsewhere, long-term care involves regular “stimulation tests” to see if the body can still produce its own cortisol [1][5].
- Central Diabetes Insipidus (83%): This is not related to blood sugar. It is a problem with the body’s water-balance hormone, leading to extreme thirst and frequent urination (polyuria-polydipsia) [1]. For known diabetes insipidus, treatment involves clinician-directed desmopressin and ensuring the child always has unrestricted access to drinking water.
- Hypogonadism (44%): This affects the hormones responsible for puberty. It may be noticed early in boys (as a small penis) or later in both boys and girls as a delay in starting puberty [1][4].
A Framework for Long-Term Monitoring
There is no universal, one-size-fits-all schedule for testing such a rare condition. Your endocrinologist will individualize testing based on your child’s age, symptoms, prior results, and current treatments. Standard monitoring generally covers:
| System | What is Monitored |
|---|---|
| Growth | Height, weight, and IGF-1 levels [1]. |
| Thyroid | Free T4 levels [1]. |
| Adrenal | Morning cortisol or ACTH stimulation tests [1]. |
| Sugar/Insulin | Blood glucose, HbA1c, and proinsulin levels [6]. |
| Water Balance | Sodium levels and urine concentration, especially during illnesses [7]. |
The Emotional Toll of “The Wait”
Chronic monitoring is a full-time job. For parents, every blood draw can feel like a high-stakes test, and “watchful waiting” for the next hormone deficiency can create significant anxiety. It is common to feel a sense of “medical trauma” from the frequent needles and hospital visits required to stay ahead of the condition.
For your child, these frequent checks can be frightening or frustrating. Many families find it helpful to:
- Create a Routine: Use a specific “bravery” reward for lab days to give the child something positive to focus on.
- Build a Medical Home: Ensure all your specialists (the “multidisciplinary team”) communicate through one central doctor (usually the endocrinologist) to avoid redundant tests.
- Focus on the Whole Child: Remember that your child is more than a set of lab values. While the numbers are vital for safety, their happiness and developmental milestones are just as important. Psychosocial support from a mental health professional can be invaluable.
Maintaining this vigilance is exhausting, but it is also empowering. By catching these changes early, you and your medical team can replace what the body is missing, allowing your child the best opportunity to grow and thrive [8][9].
Common questions in this guide
What hormone problems can develop over time with PCSK1 deficiency?
Which tests are commonly used to monitor a child with PCSK1 deficiency?
Why is free T4 used instead of TSH in central hypothyroidism?
Why should adrenal function be checked before starting thyroid hormone?
What should families know about central diabetes insipidus?
How can PCSK1 deficiency affect growth and puberty?
How often should a child with PCSK1 deficiency have endocrine tests?
One line in your results can change your plan.
Adrenal function must be evaluated before thyroid replacement is started in central hypothyroidism. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Obesity due to prohormone convertase I deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
A New Case of PCSK1 Pathogenic Variant With Congenital Proprotein Convertase 1/3 Deficiency and Literature Review.
Pépin L, Colin E, Tessarech M, et al.
The Journal of clinical endocrinology and metabolism 2019; (104(4)):985-993 doi:10.1210/jc.2018-01854.
PMID: 30383237 - 2
Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy.
Gönç EN, Özön A, Alikaşifoğlu A, Kandemir N
Journal of clinical research in pediatric endocrinology 2017; (9(3)):283-287 doi:10.4274/jcrpe.3986.
PMID: 28588004 - 3
Modulation of PC1/3 activity by a rare double-site homozygous mutation.
Ni Y, Chen X, Sun Y, et al.
Frontiers in pediatrics 2022; (10()):1026707 doi:10.3389/fped.2022.1026707.
PMID: 36389395 - 4
PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders.
Stijnen P, Ramos-Molina B, O'Rahilly S, Creemers JW
Endocrine reviews 2016; (37(4)):347-71 doi:10.1210/er.2015-1117.
PMID: 27187081 - 5
Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.
Miller BS, Spencer SP, Geffner ME, et al.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2020; (68(1)):16-25 doi:10.1136/jim-2019-000999.
PMID: 30819831 - 6
A case of prohormone convertase deficiency diagnosed with type 2 diabetes.
Karacan Küçükali G, Savaş Erdeve Ş, Çetinkaya S, et al.
Turkish archives of pediatrics 2021; (56(1)):81-84 doi:10.14744/TurkPediatriArs.2020.36459.
PMID: 34013237 - 7
Enteroendocrine Dysfunction in Two Saudi Sisters.
Ahmed ABM, Alsaleem BMR
Case reports in gastroenterology 2021; (15(1)):290-295 doi:10.1159/000511761.
PMID: 33790717 - 8
A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings.
Duclaux-Loras R, Bourgeois P, Lavrut PM, et al.
Clinics and research in hepatology and gastroenterology 2021; (45(6)):101640 doi:10.1016/j.clinre.2021.101640.
PMID: 33662777 - 9
Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial.
Argente J, Verge CF, Okorie U, et al.
The lancet. Diabetes & endocrinology 2025; (13(1)):29-37 doi:10.1016/S2213-8587(24)00273-0.
PMID: 39549719
This page explains long-term monitoring in children with PCSK1 deficiency for informational purposes only and does not constitute medical advice. Your child's pediatric endocrinologist should set testing schedules, interpret results, and guide treatment.